Navigation Links
US Peptides Discusses IGF 1 in new article series
Date:2/26/2013

TAMPA, Fla., Feb. 26, 2013 /PRNewswire-iReach/ -- Research peptides are used around the world for a number of reason but most notably to test the effects of growth hormone related hormones and growth hormone related peptides and their effects.

(Photo: http://photos.prnewswire.com/prnh/20130226/CG66671)

US Peptides carries a variety of products such as: Melanotan II, CJC-1295, GHRP-6, Sermorelin, IGF1-LR3, GHRP-2, Fragment 176-191, CJC-1295 DAC, Mechano Growth Factor – PEG, Mechano Growth Factor, Hexarelin, Ipamorelin, Melanotan I, Bacteriostatic 0.9% Sodium Chloride and hard to find Bacteriostatic Water.

Recently there has been quite a bit of exposure and media attention to a product called insulin like growth factor 1, otherwise known and IGF-1. The exposure was due to rumors of professional athletes allegedly using the products to either promote strength or muscle size or to accelerate healing in injured muscles of joints.

IGF-1 or Insulin like Growth Factor 1 is a protein encoded by the IGF1 gene and it is similar to the molecular structure of insulin. IGF 1 has many amino acids (70 in all) that are made by the endocrine hormone and the liver. Insulin like growth factor 1 has many effects within the human body and by manipulating the hormone it can lead to significant gains in the area of healing, recovery and sports performance.

Insulin like growth factor 1 supports cellular division and growth in organs and muscle cells. Igf-1 also aids in repairing nerve damage, circulatory systems, cardiovascular system and is very popular among the anti-aging crowd.

IGF-1 also aids in fat loss because it inhibits the use of insulin which slows the moving of glucose throughout the body, this function forces the body to use fat as an energy source instead of glucose.

IGF-1 in its true form is available via prescription or for research purposes, it is important to note that in many sports and in the Olympics, use of IGF-1 is banned and can result in suspension or banning of an athlete caught using it.

US Peptides has an information section dedicated to providing articles about research peptides including IGF-1 right here- http://uspeptides.com/articles/

USPeptides.com is a United States based distributor of the highest grade research Peptides and Amino Acid Derivatives available. We utilize the most advanced techniques to ensure fast and secure product delivery. These items are intended for research purposes only.

US Peptides is proud to offer high quality research grade peptides like IGF-1 for research purposes.

Media Contact: Don P US Peptides LLC, 727-210-7821, info@useptides.com 

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE US Peptides LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. US Peptides Increases Inventory on Sterile Bacteriostatic Water
2. IGF-1 and Long IGF-1 LR3 Is There a Difference? US Peptides Discusses
3. US Peptides Provides New Article Discussing HGH and Athletic Performance
4. New Florida Peptides Site offering CJC-1295, GHRP-6, Sermorelin and more!
5. Health Diagnostic Laboratory, Inc. (HDL, Inc.) Brings Advanced Testing to Capitol Hill, Discusses Health Care Cost Savings and Quality Improvement Potential
6. MDHI Provides Investor Update -- Provides Business Model Overview -- Discusses Upcoming Profitability
7. Dallas Car Wreck Lawyer Discusses Serious Consequences of Driving While Under the Influence of Drugs
8. Aethlon Medical Discusses Therapeutic Device Strategies to Address Cancer, Hepatitis-C and Sepsis with the Wall Street Transcript
9. Eaton Scientific Discusses Positive Anecdotal Feedback from Pharmacist Compounding Homatropine for Doctors Treating Patients Experiencing Hot Flash Symptoms in the Beverley Hills and Los Angeles Area.
10. US Vitamin Injections Discusses Bursitis Treatment with B12 Shots
11. Herborium(R) Group Discusses an Aftermath of the Ban of Diane-35 Acne Drug Due to Number of Deaths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Leading ... that address medical conditions resulting from a breakdown ... has appointed Greg Doyle as chief ... Leading BioSciences, executive management team and board of ... chief financial officer. He will provide continued leadership ...
(Date:6/23/2016)... June 23, 2016 Research and ... in Europe 2016 Edition: The New Global Agenda " ... OTC Distribution in Europe - ... explores and tracks change. It identifies the driving factors coming ... the consumer healthcare industry now and in the future. It ...
(Date:6/23/2016)... June 23, 2016 The ... the development of combination therapies trend is expected ... treatment of CLL were available only in the ... are chlorambucil in combination with prednisone, and a ... a growing trend of developing combination therapies to ...
Breaking Medicine Technology:
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, ... stem (iPS) cells and other difficult to transfect cells, announces its launch of ... PluriQ™ G9™ Gene Editing System is a complete system for culturing and ...
(Date:6/24/2016)... ... June 24, 2016 , ... To succeed under value-based payments, ... are unsure how to move forward, given the need to sustain current operations. ... tailored to an organization’s specific needs. , PYA Principal Martie Ross states, “Healthcare ...
Breaking Medicine News(10 mins):